eISSN: 2081-2841
ISSN: 1689-832X
Journal of Contemporary Brachytherapy
Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
6/2022
vol. 14
 
Share:
Send email
Share:
abstract:
Case report

Brachytherapy for uterine cervix-limited acute myeloid leukemia relapse

Guillaume Beziat
1
,
Suzanne Tavitian
1
,
Francois-Xavier Arnaud
2
,
Françoise Izar
3
,
Justine Attal
3
,
Cécile Borel
1
,
Christian Recher
1
,
Anne Ducassou
3

  1. Hematology Department, Institut Universitaire du Cancer de Toulouse – Oncopole, Centre Hospitalier Universitaire de Toulouse, F-31000 Toulouse, France
  2. Engineering and Medical Physics Department, Institut Universitaire du Cancer de Toulouse – Oncopole, Institut Claudius Regaud, F-31000 Toulouse, France
  3. Radiation Oncology and Brachytherapy Department, Institut Universitaire du Cancer de Toulouse – Oncopole, Institut Claudius Regaud, F-31000 Toulouse, France
J Contemp Brachytherapy 2022; 14, 6: 601–604
DOI: https://doi.org/10.5114/jcb.2022.123980
Online publish date: 2022/12/30
View full text Get citation
 
Acute myeloid leukemia (AML) may extend to extra-medullary sites at diagnosis or at relapse, either isolated or associated with bone marrow disease. Granulocytic sarcoma of uterine cervix is rare, and there is no established treatment for this disease. Two cases of uterine cervix-limited AML relapse showed that brachytherapy may be an effective therapeutic option in this setting along with chemotherapy, with good tolerance.
keywords:

acute myeloid leukemia, brachytherapy, granulocytic sarcoma

  
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.